Skip to main content
Log in

Identification of AGE-modified proteins in SH-SY5Y and OLN-93 Cells

  • Published:
Neurotoxicity Research Aims and scope Submit manuscript

Abstract

The formation of “Advanced Glycation End products” (AGEs) is an inevitable consequence of mammalian glucose metabolism. AGE-mediated protein-protein crosslinks lead to detergent-insoluble and protease-resistant protein aggregates, and in Alzheimer’s disease (AD) extra cellular senile plaques (SPs) and intracellular neurofibrillary tangles (NFTs) have been shown to contain AGEs. However, to date little is known concerning the most prevalent protein-targets of AGE modification under normal, non-pathological conditions. Here, a combination of 2D-electrophoresis, Western blotting and mass spectrometry has been used to identify preferentially AGE-modified proteins in oligodendrocyte (OLN-93) and neuroblastoma cell lines (SH-SY5Y) in standard culture. Proteomics analysis identified a total of eight targets with structural, metabolic and regulatory function, three of which (ß-actin, ß-tubulin and eukaryotic Elongation Factor 1-α) were common to both cell lines. Based on results from prior studies, modification of these proteins may lead to a loss of function. Consequently, the identification of targets for these proteins is of particular interest for a better understanding of the consequences of AGE-modification in aging, neurodegenerative diseases and diabetes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Agarwal PK, A Geist and A Gorin (2004) Protein dynamics and enzymatic catalysis: investigating the peptidyl-prolyl cis-trans isomerization activity of cyclophilin A.Biochemistry 43, 10605–10618.

    Article  PubMed  CAS  Google Scholar 

  • Ahmed N and PJ Thornalley (2002) Chromatographic assay of glycation adducts in human serum albumin glycatedin vitro by derivatization with 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and intrinsic fluorescence.Biochem. J. 364, 15–24.

    PubMed  CAS  Google Scholar 

  • Aksenov MY, MV Aksenova, DA Butterfield, JW Geddes and WR Markesbery (2001) Protein oxidation in the Alzheimer’s disease brain: analysis of protein carbonyls by immunocytochemistry and two-dimensional Western blotting.Neuroscience 103, 373–383.

    Article  PubMed  CAS  Google Scholar 

  • Arendt T (2002) Dysregulation of neuronal differentiation and cell cycle control in Alzheimer’s disease.J. Neural Transm. Suppl. 77-85.

  • Avramut M and CL Achim (2002) Immunophilins and their ligands: insights into survival and growth of human neurons.Physiol. Behav. 77, 463–468.

    Article  PubMed  CAS  Google Scholar 

  • Avramut M and CL Achim (2003) Immunophilins in nervous system degeneration and regeneration.Curr. Top. Med. Chem. 3, 1376–1382.

    Article  PubMed  CAS  Google Scholar 

  • Bachmair A, D Finley and A Varshavsky (1986)In vivo half-life of a protein is a function of its amino-terminal residue.Science 234, 179–186.

    Article  PubMed  CAS  Google Scholar 

  • Baynes JW (2002) The Maillard hypothesis on aging: time to focus on DNA.Ann. NYAcad. Sci. 959, 360–367.

    Article  CAS  Google Scholar 

  • Berg D, C Holzmann and O Riess (2003) 14-3-3 Proteins in the nervous system.Nat. Rev. Neurosci. 40, 752–762.

    Article  CAS  Google Scholar 

  • Bevec D, H Klier, W Holter, E Tschachler, P Valent, F Lottspeich, T Baumrukerand J Hauber (1994) Induced gene expression of the hypusine-containing protein eukaryotic initiation factor 5A in activated human T lymphocytes.Proc. Natl. Acad. Sci. USA 91, 10829–10833.

    Article  PubMed  CAS  Google Scholar 

  • Bommer UA and BJ Thiele (2004) The translationally controlled tumour protein (TCTP).Int. J. Biochem. Cell. Biol. 36, 379–385.

    Article  PubMed  CAS  Google Scholar 

  • Bousova I, D Vukasovic, D Juretic, V Palicka and J Drsata (2005) Enzyme activity and AGE formation in a model of AST glycoxidation by D-fructosein vitro. Acta Pharm. 55, 107–114.

    CAS  Google Scholar 

  • Boyd-Kimball D, A Castegna, R Sultana, HF Poon, R Petroze, BC Lynn, JB Klein and DA Butterfield (2005) Proteomic identification of proteins oxidized by Aß(1-42) in synaptosomes: implications for Alzheimer’s disease.Brain Res. 1044, 206–215.

    Article  PubMed  CAS  Google Scholar 

  • Brock JW, DJ Hinton, WE Cotham, TO Metz, SR Thorpe, JW Baynes and JM Ames (2003) Proteomic analysis of the site specificity of glycation and carboxymethylation of ribonuclease.J. Proteome Res. 2, 506–513.

    Article  PubMed  CAS  Google Scholar 

  • Butterfield DA (2004) Proteomics: a new approach to investigate oxidative stress in Alzheimer’s disease brain.Brain Res. 1000, 1–7.

    Article  PubMed  CAS  Google Scholar 

  • Butterfield DA, D Boyd-Kimball and A Castegna (2003) Proteomics in Alzheimer’s disease: insights into mechanisms of neurodegeneration.J. Neurochem. 86, 1313–1327.

    Article  PubMed  CAS  Google Scholar 

  • Cans C, BJ Passer, V Shalak, V Nancy-Portebois, V Crible, N Amzallag, D Allanic, R Tufino, M Argentini, D Moras, G Fiucci, B Goud, M Mirande, R Amson and A Telerman (2003) Translationally controlled tumor protein acts as a guanine nucleotide dissociation inhibitor on the translation elongation factor eEF1A.Proc. Natl. Acad. Sci. USA 100, 13892–13897.

    Article  PubMed  CAS  Google Scholar 

  • Caraglia M, M Marra, G Giuberti, AM D’Alessandro, A Budillon, S del Prete, A Lentini, S Beninati and A Abbruzzese (2001) The role of eukaryotic initiation factor 5 A in the control of cell proliferation and apoptosis.Amino Acids 20, 91–104.

    Article  PubMed  CAS  Google Scholar 

  • Clarkson E, CF Costa and LM Machesky (2004) Congenital myopathies: diseases of the actin cytoskeleton.J. Pathol. 204, 407–417.

    Article  PubMed  CAS  Google Scholar 

  • Clement PM, CA Henderson, ZA Jenkins, Z Smit-McBride, EC Wolff, JW Hershey, MH Park and HE Johansson (2003) Identification and characterization of eukaryotic initiation factor 5A-2.Eur. J. Biochem. 270, 4254–4263.

    Article  PubMed  CAS  Google Scholar 

  • de Arriba SG, C Loske, I Meiners, G Fleischer, M Lobisch, K Wessel, H Tritschler, R Schinzel and G Munch (2003) Advanced glycation endproducts induce changes in glucose consumption, lactate production, and ATP levels in SH-SY5Y neuroblastoma cells by a redox-sensitive mechanism.J. Cereb. Blood Flow Metab. 23, 1307–1313.

    Article  PubMed  CAS  Google Scholar 

  • Downing KH and E Nogales (1999) Crystallographic structure of tubulin: implications for dynamics and drug binding.Cell Struct. Funct. 24, 269–275.

    Article  PubMed  CAS  Google Scholar 

  • Dukic-Stefanovic S, D Schicktanz, A Wong, D Palm, P Riederer, T Niwa, R Schinzel and G Munch (2002) Characterization of antibody affinities using an AGE-modified dipeptide spot library.J. Immunol. Methods 266, 45–52.

    Article  PubMed  CAS  Google Scholar 

  • Dukic-Stefanovic S, J Gasic-Milenkovic, W Deuther-Conrad and G Munch (2003) Signal transduction pathways in mouse microglia N-11 cells activated by advanced glycation endproducts (AGEs).J. Neurochem. 87, 44–55.

    Article  PubMed  CAS  Google Scholar 

  • Ejiri S (2002) Moonlighting functions of polypeptide elongation factor 1: from actin bundling to zinc finger protein R1-associated nuclear localization.Biosci. Biotechnol. Biochem. 66, 1–21.

    Article  PubMed  CAS  Google Scholar 

  • Fasman GD (1989) Predictions of protein structure and the principles of protein conformation.Planum Press.

  • Gachet Y, S Tournier, M Lee, A Lazaris-Karatzas, T Poulton and UA Bommer (1999) The growth-related, translationally controlled protein P23 has properties of a tubulin binding protein and associates transiently with microtubules during the cell cycle.J. Cell. Sci. 112 (Pt 8), 1257–1271.

    PubMed  CAS  Google Scholar 

  • Galbraith JA and PE Gallant (2000) Axonal transport of tubulin and actin.J. Neurocytol. 29, 889–911.

    Article  PubMed  CAS  Google Scholar 

  • Ganoza MC, MC Kiel and H Aoki (2002) Evolutionary conservation of reactions in translation.Microbiol. Mol. Biol. Rev. 66, 460–85, table.

    Article  PubMed  CAS  Google Scholar 

  • Gasic-Milenkovic J, S Dukic-Stefanovic, W Deuther-Conrad, U Gartner and G Munch (2003) beta-Amyloid peptide potentiates inflammatory responses induced by lipopolysaccharide, interferon-gamma and ‘advanced glycation endproducts’ in a murine microglia cell line.Eur. J. Neurosci. 17, 813–821.

    Article  PubMed  Google Scholar 

  • Giardino I, D Edelstein and M Brownlee (1994) Nonenzymatic glycosylationin vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. A model for intracellular glycosylation in diabetes.J. Clin. Invest. 94, 110–117.

    Article  PubMed  CAS  Google Scholar 

  • Gorg A, C Obermaier, G Boguth, A Harder, B Scheibe, R Wildgruber and W Weiss (2000) The current state of two-dimensional electrophoresis with immobilized pH gradients.Electrophoresis 21, 1037–1053.

    Article  PubMed  CAS  Google Scholar 

  • Gothel SF and MA Marahiel (1999) Peptidyl-prolyl cis-trans isomerases, a superfamily of ubiquitous folding catalysts.Cell. Mol. Life Sci. 55, 423–436.

    Article  PubMed  CAS  Google Scholar 

  • Gutala RV and PH Reddy (2004) The use of real-time PCR analysis in a gene expression study of Alzheimer’s diseasepost-mortem brains.J. Neurosci. Methods 132, 101–107.

    Article  PubMed  CAS  Google Scholar 

  • Hasenkopf K, B Ronner, H Hiller and M Pischetsrieder (2002) Analysis of glycated and ascorbylated proteins by gas chromatography-mass spectrometry.J. Agric. Food Chem. 50, 5697–5703.

    Article  PubMed  CAS  Google Scholar 

  • Hashiguchi M, K Sobue and HK Paudel (2000) 14-3-3Zeta is an effector of tau protein phosphorylation.J. Biol. Chem. 275, 25247–25254.

    Article  PubMed  CAS  Google Scholar 

  • Hershey JW (1991) Translational control in mammalian cells.Annu. Rev. Biochem. 60, 717–755.

    Article  PubMed  CAS  Google Scholar 

  • Horie K, T Miyata, K Maeda, S Miyata, S Sugiyama, H Sakai, DS van Ypersole, V Monnier, JL Witztum and K Kurokawa (1997) Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy.J. Clin. Invest. 100, 2995–3004.

    Article  PubMed  CAS  Google Scholar 

  • Jensen ON, M Wilm, A Shevchenko and M Mann (1999) Sample preparation methods for mass spectrometric peptide mapping directly from 2-DE gels.Methods Mol. Biol. 112, 513–530.

    PubMed  CAS  Google Scholar 

  • Jin ZG, MG Melaragno, DF Liao, C Yan, J Haendeler, YA Suh, JD Lambeth and BC Berk (2000) Cyclophilin A is a secreted growth factor induced by oxidative stress.Circ. Res. 87, 789–796.

    PubMed  CAS  Google Scholar 

  • Johnson G, J Gotlib, V Haroutunian, L Bierer, AC Nairn, C Merril and W Wallace (1992) Increased phosphorylation of elongation factor 2 in Alzheimer’s disease.Brain Res. Mol. Brain Res. 15, 319–326.

    Article  PubMed  CAS  Google Scholar 

  • Kabsch W and KC Holmes (1995) The actin fold.FASEB J. 9, 167–174.

    PubMed  CAS  Google Scholar 

  • Kennedy L and JW Baynes (1984) Non-enzymatic glycosylation and the chronic complications of diabetes: an overview.Diabetologia 26, 93–98.

    Article  PubMed  CAS  Google Scholar 

  • Kikuchi S, K Shinpo, M Takeuchi, S Yamagishi, Z Makita, N Sasaki and K Tashiro (2003) Glycation - a sweet tempter for neuronal death.Brain Res. Brain Res. Rev. 41, 306–323.

    Article  PubMed  CAS  Google Scholar 

  • Kil IS, JH Lee, AH Shin and JW Park (2004) Glycation-induced inactivation of NADP(+)-dependent isocitrate dehydrogenase: implications for diabetes and aging.Free Radic. Biol. Med. 37, 1765–1778.

    Article  PubMed  CAS  Google Scholar 

  • Kozak M (1999) Initiation of translation in prokaryotes and eukaryotes.Gene 234, 187–208.

    Article  PubMed  CAS  Google Scholar 

  • Lee HJ, SK Howell, RJ Sanford and PJ Beisswenger (2005) Methylglyoxal can modify GAPDH activity and structure. Ann.NY Acad. Sci. 1043, 135–145.

    Article  CAS  Google Scholar 

  • Loske C, A Neumann, AM Cunningham, K Nichol, R Schinzel, P Riederer and G Munch (1998) Cytotoxicity of advanced glycation endproducts is mediated by oxidative stress.J. Neural Transm. 105, 1005–1015.

    Article  PubMed  CAS  Google Scholar 

  • Lue LF, DG Walkerand J Rogers (2001) Modeling microglial activation in Alzheimer’s disease with humanpostmortem microglial cultures.Neurobiol. Aging 22, 945–956.

    Article  PubMed  CAS  Google Scholar 

  • Medori R, H Jenich, L Autilio-Gambettiand P Gambetti (1988) Experimental diabetic neuropathy: similar changes of slow axonal transport and axonal size in different animal models.J. Neurosci. 8, 1814–1821.

    PubMed  CAS  Google Scholar 

  • Miyata T, N Ishiguro, Y Yasuda, T Ito, M Nangaku, H Iwata and K Kurokawa (1998) Increased pentosidine, an advanced glycation end product, in plasma and synovial fluid from patients with rheumatoid arthritis and its relation with inflammatory markers.Biochem. Biophys. Res. Commun. 244, 45–49.

    Article  PubMed  CAS  Google Scholar 

  • Monnier VM and A Cerami (1981) Nonenzymatic browning in vivo: possible process for aging of long-lived proteins.Science 211, 491–493.

    Article  PubMed  CAS  Google Scholar 

  • Munch G, R Schinzel, C Loske, A Wong, N Durany, JJ Li, H Vlassara, MA Smith, G Perry and P Riederer (1998) Alzheimer’s disease-synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts.J. Neural Transm. 105, 439–461.

    Article  PubMed  CAS  Google Scholar 

  • Munch G, D Schicktanz, A Behme, M Gerlach, P Riederer, D Palm and R Schinzel (1999) Amino acid specificity of glycation and protein-AGE crosslinking reactivities determined with a dipeptide SPOT library.Nat. Biotechnol. 17, 1006–1010.

    Article  PubMed  CAS  Google Scholar 

  • Munch G, B Kuhla, HJ Luth, T Arendt and SR Robinson (2003) Anti-AGEing defences against Alzheimer’s disease.Biochem. Soc. Trans. 31, 1397–1399.

    Article  PubMed  CAS  Google Scholar 

  • Nagai R, CM Hayashi, L Xia, M Takeya and S Horiuchi (2002) Identification in human atherosclerotic lesions of GA-pyridine, a novel structure derived from glycolaldehyde-modified proteins.J. Biol. Chem. 277, 48905–48912

    Article  PubMed  CAS  Google Scholar 

  • Nakamura K, Y Nakazawa and K Ienaga (1997) Acid-stable fluorescent advanced glycation end products: vesperlysines A, B, and C are formed as crosslinked products in the Maillard reaction between lysine or proteins with glucose.Biochem. Biophys. Res. Commun. 232, 227–230.

    Article  PubMed  CAS  Google Scholar 

  • Neye H (2000) [Immunophilins: having immunosuppressive activity and physiological function].Pharm. Unserer Zeit 29, 297–302.

    Article  PubMed  CAS  Google Scholar 

  • Pamplona R, E Dalfo, V Ayala, MJ Bellmunt, J Prat, I Ferrer and M Portero-Otin (2005) Proteins in human brain cortex are modified by oxidation, glycoxidation, and lipoxidation. Effects of Alzheimer disease and identification of lipoxidation targets.J. Biol. Chem. 280, 21522–21530.

    Article  PubMed  CAS  Google Scholar 

  • Pancholi V (2001) Multifunctional alpha-enolase: its role in diseases.Cell. Mol. Life Sci. 58, 902–920.

    Article  PubMed  CAS  Google Scholar 

  • Park MH (1987) Regulation of biosynthesis of hypusine in Chinese hamster ovary cells. Evidence for eIF-4D precursor polypeptides.J. Biol. Chem. 262, 12730–12734.

    PubMed  CAS  Google Scholar 

  • Park MH, SI Chung, HL Cooper and JE Folk (1984) The mammalian hypusine-containing protein, eukaryotic initiation factor 4D. Structural homology of this protein from several species.J. Biol. Chem. 259, 4563–4565.

    PubMed  CAS  Google Scholar 

  • Pawlowski PG and R Dringen (2003) Identification of Nepsilon-(carboxymethyl)lysine-positive cells in astroglia-rich primary cultures.J. Neural Transm. 110, 1077–1090.

    Article  PubMed  CAS  Google Scholar 

  • Poggioli S, H Bakala and B Friguet (2002) Age-related increase of protein glycation in peripheral blood lymphocytes is restricted to preferential target proteins.Exp. Gerontol. 37, 1207–1215.

    Article  PubMed  CAS  Google Scholar 

  • Poon HF, A Castegna, SA Farr, V Thongboonkerd, BC Lynn, WA Banks, JE Morley, JB Klein and DA Butterfield (2004) Quantitative proteomics analysis of specific protein expression and oxidative modification in aged senescence-accelerated-prone 8 mice brain.Neuroscience 126, 915–926.

    Article  PubMed  CAS  Google Scholar 

  • Reynet C and CR Kahn (2001) Unbalanced expression of the different subunits of elongation factor 1 in diabetic skeletal muscle.Proc. Natl. Acad. Sci. USA 98, 3422–3427.

    Article  PubMed  CAS  Google Scholar 

  • Richter T, G Munch, HJ Luth, T Arendt, R Kientsch-Engel, P Stahl, D Fengler and B Kuhla (2005) Immunochemical crossreactivity of antibodies specific for “advanced glycation endproducts” with “advanced lipoxidation endproducts”.Neurobiol. Aging 26, 465–474.

    Article  PubMed  CAS  Google Scholar 

  • Sasaki N, R Fukatsu, K Tsuzuki, Y Hayashi, T Yoshida, N Fujii, T Koike, I Wakayama, R Yanagihara, R Garruto, N Amano and Z Makita (1998) Advanced glycation end products in Alzheimer’s disease and other neurodegenerative diseases.Am. J. Pathol. 153, 1149–1155.

    PubMed  CAS  Google Scholar 

  • Selvaggini C, L De Gioia, L Cantu, E Ghibaudi, L Diomede, F Passerini, G Forloni, O Bugiani, F Tagliavini and M Salmona (1993) Molecular characteristics of a protease-resistant, amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein.Biochem. Biophys. Tes. Commun. 194, 1380–1386.

    Article  CAS  Google Scholar 

  • Steinberg TH, LJ Jones, RP Haugland and VL Singer (1996) SYPRO orange and SYPRO red protein gel stains: one-step fluorescent staining of denaturing gels for detection of nanogram levels of protein.Anal. Biochem. 239, 223–237.

    Article  PubMed  CAS  Google Scholar 

  • Talent JM, Y Kong and RW Gracy (1998) A double stain for total and oxidized proteins from two-dimensional fingerprints.Anal. Biochem. 263, 31–38.

    Article  PubMed  CAS  Google Scholar 

  • Thiele H, M Berger, A Skalweit and BJ Thiele (2000) Expression of the gene and processed pseudogenes encoding the human and rabbit translationally controlled tumour protein (TCTP).Eur. J. Biochem. 267, 5473–5481.

    Article  PubMed  CAS  Google Scholar 

  • Thongboonkerd V, J Luengpailin, J Cao, WM Pierce, J Cai, JB Klein and RJ Doyle (2002) Fluoride exposure attenuates expression of Streptococcus pyogenes virulence factors.J. Biol. Chem. 277, 16599–16605.

    Article  PubMed  CAS  Google Scholar 

  • Thornalley PJ (1998) Cell activation by glycated proteins. AGE receptors, receptor recognition factors and functional classification of AGEs.Cell. Mol. Biol. (Noisy-le-grand) 44, 1013–1023.

    CAS  Google Scholar 

  • Thornalley PJ, S Battah, N Ahmed, N Karachalias, S Agalou, R Babaei-Jadidi and A Dawnay (2003) Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry.Biochem. J. 375, 581–592.

    Article  PubMed  CAS  Google Scholar 

  • Tzivion G and J Avruch (2002) 14-3-3 Proteins: active cofactors in cellular regulation by serine/threonine phosphorylation.J. Biol. Chem. 277, 3061–3064.

    Article  PubMed  CAS  Google Scholar 

  • Tzivion G, YH Shen and J Zhu (2001) 14-3-3 Proteins; bringing new definitions to scaffolding.Oncogene 20, 6331–6338.

    Article  PubMed  CAS  Google Scholar 

  • Ueberham U, A Hessel and T Arendt (2003) Cyclin C expression is involved in the pathogenesis of Alzheimer’s disease.Neurobiol. Aging 24, 427–435.

    Article  PubMed  CAS  Google Scholar 

  • Verzar F (1964) Aging of the collagen fiber.Int. Rev. Connect. Tissue Res. 2, 243–300.

    PubMed  CAS  Google Scholar 

  • Vijayan S, E El Akkad, I Grundke-Iqbal and K Iqbal (2001) A pool of beta-tubulin is hyperphosphorylated at serine residues in Alzheimer disease brain.FEBSLett. 509, 375–381.

    Article  CAS  Google Scholar 

  • Vogelsberg-Ragaglia V, T Schuck, JQ Trojanowski and VM Lee (2001) PP2A mRNA expression is quantitatively decreased in Alzheimer’s disease hippocampus.Exp. Neurol. 168, 402–412.

    Article  PubMed  CAS  Google Scholar 

  • Walsh CT, LD Zydowsky and FD McKeon (1992) Cyclosporin A, the cyclophilin class of peptidylprolyl isomerases, and blockade of T cell signal transduction.J. Biol. Chem. 267, 13115–13118.

    PubMed  CAS  Google Scholar 

  • Westhead EW (1966) Enolase from yeast and rabbit muscle.Methods Enzymol. 9, 670–679.

    Article  CAS  Google Scholar 

  • Williams SK, NL Howarth, JJ Devenny and MW Bitensky (1982) Structural and functional consequences of increased tubulin glycosylation in diabetes mellitus.Proc. Natl. Acad. Sci. USA 79, 6546–6550.

    Article  PubMed  CAS  Google Scholar 

  • Wistow GJ, T Lietman, LA Williams, SO Stapel, WW de Jong, J Horwitz and J Piatigorsky (1988) Tau-crystallin/alpha-enolase: one gene encodes both an enzyme and a lens structural protein.J. Cell. Biol. 107, 2729–2736.

    Article  PubMed  CAS  Google Scholar 

  • Yaffe MB (2002) How do 14-3-3 proteins work?-- Gatekeeper phosphorylation and the molecular anvil hypothesis.FEBS Lett. 513, 53–57.

    Article  PubMed  CAS  Google Scholar 

  • Yan H and JJ Harding (2005) Carnosine protects against the inactivation of esterase induced by glycation and a steroid.Biochim. Biophys. Acta 1741, 120–126.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to AndrÉ K. Langer or D. Allan Butterfield.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Langer, A.K., Poon, H.F., Münch, G. et al. Identification of AGE-modified proteins in SH-SY5Y and OLN-93 Cells. neurotox res 9, 255–268 (2006). https://doi.org/10.1007/BF03033316

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03033316

Keywords

Navigation